REQUEST A DEMO
Total
USD $0.00
Search more companies

VIOL Co., Ltd. (South Korea)

Main Activities: Electromedical and Electrotherapeutic Apparatus Manufacturing
Full name: VIOL Co., Ltd. Profile Updated: June 19, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

The Company is a Korea-based company mainly engaged in the manufacture and sale of medical devices for skin beauty. The Company s main product is Scarlet, an equipment for elasticity and lifting. In addition, the Company develops and produces medical devices for anti-aging skin care. The Company sells its products in domestic and overseas markets such as China and the United States. The Company was established on September 2, 2019. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on December 3, 2019.

Headquarters
808, 809, Bundang Technopark C, 744, Pangyo-Ro, Bundang-Gu
Seongnam; Gyeonggi;

Contact Details: Purchase the VIOL Co., Ltd. report to view the information.

Website: http://www.viol.co.kr

Basic Information
Total Employees:
Purchase the VIOL Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the VIOL Co., Ltd. report to view the information.
Registered Capital:
Purchase the VIOL Co., Ltd. report to view the information.
Financial Auditors:
Purchase the VIOL Co., Ltd. report to view the information.
Incorporation Date:
September 02, 2019
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Company Performance
Financial values in the chart are available after VIOL Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
10.8%
Total operating revenue
10.44%
Operating profit (EBIT)
-4.55%
EBITDA
-3.74%
Net Profit (Loss) for the Period
-24.19%
Total assets
35.24%
Total equity
39.08%
Operating Profit Margin (ROS)
-8.45%
Net Profit Margin
-17.97%
Return on Equity (ROE)
-9.62%
Debt to Equity Ratio
-0.65%
Quick Ratio
5.77%
Cash Ratio
3.72%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?